Pamela L Horn-Ross1, Alison J Canchola2, Leslie Bernstein3, Dennis Deapen4, James V Lacey3, Eunjung Lee4, David O Nelson5, Peggy Reynolds5,6. 1. Cancer Prevention Institute of California, 2201 Walnut Ave., Suite 300, Fremont, CA, 94538, USA. pamhornross@gmail.com. 2. Cancer Prevention Institute of California, 2201 Walnut Ave., Suite 300, Fremont, CA, 94538, USA. 3. Department of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA. 4. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angles, CA, USA. 5. Cancer Prevention Institute of California, Berkeley, CA, USA. 6. Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA.
Abstract
PURPOSE: Obesity is a public health epidemic and a major risk factor for endometrial cancer. Here, we identify key aspects of body size which jointly, over the life-course (since adolescence), are associated with endometrial cancer risk. METHODS: Among 88,142 participants in the California Teachers Study, 887 were diagnosed with invasive type 1 endometrial cancer between 1997-1998 and 2012. Multivariable Cox proportional hazards models provided estimates of hazard rate ratios (HR) and 95% confidence intervals (CI) for endometrial cancer associated with life-course body size phenotypes, which incorporated validated measures. RESULTS: Among women currently using hormone therapy, endometrial cancer risk was only associated with height (HR 1.78, 95% CI 1.32-2.40 for ≥67 vs. <67 inches). Among women not using hormone therapy, tall women who were overweight/obese in adolescence (HR 4.33, 95% CI 2.51-7.46) or who became overweight/obese as adults (HR 4.74, 95% CI 2.70-8.32) were at greatest risk. CONCLUSIONS: Considering absolute body mass, changes in adiposity over time, and body fat distribution together, instead of each measure alone, we identified lifetime obesity phenotypes associated with endometrial cancer risk. These results more clearly define specific risk groups, and may explain inconsistent findings across studies, improve risk prediction models, and aid in developing targeted interventions for endometrial cancer.
PURPOSE: Obesity is a public health epidemic and a major risk factor for endometrial cancer. Here, we identify key aspects of body size which jointly, over the life-course (since adolescence), are associated with endometrial cancer risk. METHODS: Among 88,142 participants in the California Teachers Study, 887 were diagnosed with invasive type 1 endometrial cancer between 1997-1998 and 2012. Multivariable Cox proportional hazards models provided estimates of hazard rate ratios (HR) and 95% confidence intervals (CI) for endometrial cancer associated with life-course body size phenotypes, which incorporated validated measures. RESULTS: Among women currently using hormone therapy, endometrial cancer risk was only associated with height (HR 1.78, 95% CI 1.32-2.40 for ≥67 vs. <67 inches). Among women not using hormone therapy, tall women who were overweight/obese in adolescence (HR 4.33, 95% CI 2.51-7.46) or who became overweight/obese as adults (HR 4.74, 95% CI 2.70-8.32) were at greatest risk. CONCLUSIONS: Considering absolute body mass, changes in adiposity over time, and body fat distribution together, instead of each measure alone, we identified lifetime obesity phenotypes associated with endometrial cancer risk. These results more clearly define specific risk groups, and may explain inconsistent findings across studies, improve risk prediction models, and aid in developing targeted interventions for endometrial cancer.
Entities:
Keywords:
Body size; Endometrial cancer; Height; Life-course; Obesity
Authors: Emma J Crosbie; Marcel Zwahlen; Henry C Kitchener; Matthias Egger; Andrew G Renehan Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-10-28 Impact factor: 4.254
Authors: Leslie Bernstein; Mark Allen; Hoda Anton-Culver; Dennis Deapen; Pamela L Horn-Ross; David Peel; Richard Pinder; Peggy Reynolds; Jane Sullivan-Halley; Dee West; William Wright; Al Ziogas; Ronald K Ross Journal: Cancer Causes Control Date: 2002-09 Impact factor: 2.506
Authors: Marcelle M Dougan; Susan E Hankinson; Immaculata De Vivo; Shelley S Tworoger; Robert J Glynn; Karin B Michels Journal: Int J Cancer Date: 2015-02-05 Impact factor: 7.396
Authors: Victoria L Stevens; Eric J Jacobs; Alpa V Patel; Juzhong Sun; Susan M Gapstur; Marjorie L McCullough Journal: Cancer Causes Control Date: 2014-01-01 Impact factor: 2.506
Authors: Christine Friedenreich; Anne Cust; Petra H Lahmann; Karen Steindorf; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sylvie Mesrine; Jakob Linseisen; Sabine Rohrmann; Heiner Boeing; Tobias Pischon; Anne Tjønneland; Jytte Halkjaer; Kim Overvad; Michelle Mendez; M L Redondo; Carmen Martinez Garcia; Nerea Larrañaga; María-José Tormo; Aurelio Barricarte Gurrea; Sheila Bingham; Kay-Tee Khaw; Naomi Allen; Tim Key; Antonia Trichopoulou; Effie Vasilopoulou; Dimitrios Trichopoulos; Valeria Pala; Domenico Palli; Rosario Tumino; Amalia Mattiello; Paolo Vineis; H Bas Bueno-de-Mesquita; Petra H M Peeters; Göran Berglund; Jonas Manjer; Eva Lundin; Annekatrin Lukanova; Nadia Slimani; Mazda Jenab; Rudolf Kaaks; Elio Riboli Journal: Cancer Causes Control Date: 2007-02-12 Impact factor: 2.506
Authors: P H Lahmann; M Schulz; K Hoffmann; H Boeing; A Tjønneland; A Olsen; K Overvad; T J Key; N E Allen; K-T Khaw; S Bingham; G Berglund; E Wirfält; F Berrino; V Krogh; A Trichopoulou; P Lagiou; D Trichopoulos; R Kaaks; E Riboli Journal: Br J Cancer Date: 2005-09-05 Impact factor: 7.640
Authors: Daniela Mariosa; Karl Smith-Byrne; Tom G Richardson; Pietro Ferrari; Marc J Gunter; Nikos Papadimitriou; Neil Murphy; Sofia Christakoudi; Konstantinos K Tsilidis; Elio Riboli; David Muller; Mark P Purdue; Stephen J Chanock; Rayjean J Hung; Christopher I Amos; Tracy A O'Mara; Pilar Amiano; Fabrizio Pasanisi; Miguel Rodriguez-Barranco; Vittorio Krogh; Anne Tjønneland; Jytte Halkjær; Aurora Perez-Cornago; María-Dolores Chirlaque; Guri Skeie; Charlotta Rylander; Kristin Benjaminsen Borch; Dagfinn Aune; Alicia K Heath; Heather A Ward; Matthias Schulze; Catalina Bonet; Elisabete Weiderpass; George Davey Smith; Paul Brennan; Mattias Johansson Journal: J Natl Cancer Inst Date: 2022-09-09 Impact factor: 11.816